Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by C. Celeghini
The Sorafenib Plus Nutlin-3 Combination Promotes Synergistic Cytotoxicity in Acute Myeloid Leukemic Cells Irrespectively of FLT3 and P53 Status
Haematologica
Hematology
Related publications
A Novel Combination Therapy Approach for the Treatment of Acute Myeloid Leukemia: The Multi-Kinase Inhibitor Sorafenib and the HDM2 Inhibitor Nutlin-3
Haematologica
Hematology
mTOR Signaling Is Activated by FLT3 Kinase and Promotes Survival of FLT3-mutated Acute Myeloid Leukemia Cells
Molecular Cancer
Cancer Research
Oncology
Molecular Medicine
Patterns of Molecular Response to and Relapse After Combination of Sorafenib, Idarubicin, and Cytarabine in Patients With FLT3 Mutant Acute Myeloid Leukemia
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
MYC Inhibition Plus P53 Stabilization Targets Leukemic Stem Cells
Cancer Discovery
Oncology
FLT3 Inhibitors in the Treatment of Acute Myeloid Leukemia
Cancer
Cancer Research
Oncology
Correlation Analysis of P53 Protein Isoforms With NPM1/FLT3 Mutations and Therapy Response in Acute Myeloid Leukemia
Oncogene
Cancer Research
Genetics
Molecular Biology
Nutlin-3 Enhances the Bortezomib Sensitivity of P53-Defective Cancer Cells by Inducing Paraptosis
Experimental and Molecular Medicine
Biochemistry
Medicine
Clinical Biochemistry
Molecular Biology
Molecular Medicine
Examination of the FLT3 and NPM1 Mutational Status in Patients With Acute Myeloid Leukemia From Southeastern Poland
Archives of Medical Science
Medicine
Synergistic Cell Death in FLT3-ITD Positive Acute Myeloid Leukemia by Combined Treatment With Metformin and 6-Benzylthioinosine
Leukemia Research
Cancer Research
Oncology
Hematology
